Evaxion Biotech Correlations

EVAX Stock

USD 4.34 0.27 6.63%

Current 90-days correlation between Evaxion Biotech AS and Mural Oncology Plc is 0.07 (i.e., Very good diversification).The correlation coefficient ranges from -1 to +1 and quantifies how closely the stock co-moves with paired assets.

Evaxion Biotech Market Correlation

Excellent diversification

Across the chosen horizon, Evaxion Biotech and Dow Jones show a correlation of -0.03 and fall into the Excellent diversification bucket. Lower overlap tends to improve diversification, while higher overlap means both positions carry similar risk.

Evaxion Biotech has a market cap of 36.78 million, an operating margin of -122.66% (TTM), current ratio of 6.47. Operating margin direction often leads stock price movement over multi-quarter periods. Allocation models determine the relative weighting of each position in the portfolio. Broader economic conditions can influence Evaxion Biotech AS's company valuation - related indicators include signals in nation.

Moving Together With Evaxion Biotech Stock

0.65	CSCO	Cisco Systems Earnings Call This Week	Pair Corr
0.69	INTC	Intel Buyout Trend	Pair Corr

Moving Differently From Evaxion Biotech Stock

0.75	EQC	Equity Commonwealth	Pair Corr
0.74	HD	The Home Depot	Pair Corr
0.73	PG	Procter Gamble	Pair Corr
0.66	T	ATT Inc	Pair Corr
0.64	GE	GE Aerospace	Pair Corr
0.46	MRK	Merck Company	Pair Corr
0.37	DD	Dupont De Nemours	Pair Corr
0.34	KO	The Coca Cola Sell-off Trend	Pair Corr

Related Correlations Analysis

	RVPH	MURA	ANVS	PYPD	GBIO	BCAB	VERU	SABS	CELU	BTAI
RVPH		0.02	0.62	-0.06	-0.65	0.73	0.46	0.47	0.3	0.72	RVPH
MURA	0.02		-0.01	-0.26	-0.02	0.25	0.2	0.29	0.71	0.17	MURA
ANVS	0.62	-0.01		-0.43	-0.65	0.79	0.37	0.35	0.23	0.86	ANVS
PYPD	-0.06	-0.26	-0.43		0.37	-0.32	-0.18	0.04	-0.33	-0.4	PYPD
GBIO	-0.65	-0.02	-0.65	0.37		-0.56	-0.49	-0.28	-0.21	-0.63	GBIO
BCAB	0.73	0.25	0.79	-0.32	-0.56		0.37	0.51	0.38	0.86	BCAB
VERU	0.46	0.2	0.37	-0.18	-0.49	0.37		0.23	0.39	0.33	VERU
SABS	0.47	0.29	0.35	0.04	-0.28	0.51	0.23		0.3	0.44	SABS
CELU	0.3	0.71	0.23	-0.33	-0.21	0.38	0.39	0.3		0.3	CELU
BTAI	0.72	0.17	0.86	-0.4	-0.63	0.86	0.33	0.44	0.3		BTAI
	RVPH	MURA	ANVS	PYPD	GBIO	BCAB	VERU	SABS	CELU	BTAI

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BTAI	+ 0.86	ANVS
BTAI	+ 0.86	BCAB
BCAB	+ 0.79	ANVS
BCAB	+ 0.73	RVPH
BTAI	+ 0.72	RVPH
CELU	+ 0.71	MURA

High negative correlations

GBIO	- 0.65	ANVS
GBIO	- 0.65	RVPH
BTAI	- 0.63	GBIO
BCAB	- 0.56	GBIO
VERU	- 0.49	GBIO
PYPD	- 0.43	ANVS

Risk-Adjusted Indicators

Strong recent returns in Evaxion Biotech Stock do not always mean Evaxion Biotech Company is outperforming peers on business quality. Risk-adjusted metrics help compare Evaxion Biotech's efficiency and downside exposure against peers on a like-for-like basis. These indicators are quantitative in nature and measure volatility and risk-adjusted expected returns across different positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RVPH	6.32	-2.23	0.00	-7.06	0.00	0.00	11.25	-15.60	69.07
MURA	0.38	-0.03	0.00	0.93	0.00	0.00	0.96	-0.48	4.78
ANVS	4.26	-0.02	0.00	-0.05	0.00	0.00	10.95	-6.33	41.87
PYPD	1.93	-0.08	0.00	0.40	0.00	0.00	4.04	-3.73	10.06
GBIO	1.60	0.06	0.03	-7.10	2.17	-1.89	3.39	-3.99	14.01
BCAB	6.84	-0.80	0.00	0.61	0.00	0.00	12.50	-13.08	41.61
VERU	2.18	-0.14	0.00	0.39	0.00	0.00	3.76	-4.71	11.52
SABS	3.01	-0.15	0.00	1.59	0.00	0.00	6.34	-7.22	21.29
CELU	3.18	-0.37	0.00	0.62	0.00	0.00	7.76	-7.69	26.44
BTAI	4.16	-0.16	0.00	0.11	0.00	0.00	10.74	-8.05	27.30

Evaxion Biotech Corporate Management

DMSC MD	Chief Officer	Profile
Jrgen EMBA	Head Board	Profile
Bo Karmark	Chief Officer	Profile
Jesper Nissen	Chief Officer	Profile
Thomas Schmidt	Interim Officer	Profile